CLO21-022: Efficacy and Safety Outcomes With Therapies for Stage I-III Merkel Cell Carcinoma (MCC): A Systematic Literature Review

Authors: David Miller MD, PhD1, Roberto Palencia MA2, Ting Yu MD3, Amrita Sandhu MSc4, Sarah Webb PhD4, Tom Blaikie MChem4, and Murtuza Bharmal PhD3
View More View Less
  • 1 Massachusetts General Hospital, Boston, MA
  • | 2 Merck KGaA, Darmstadt, Germany
  • | 3 EMD Serono, Inc., Rockland, MA; an affiliate of Merck KGaA, Darmstadt, Germany
  • | 4 OPEN VIE (an OPEN Health Company), London, United Kingdom
Restricted access

Corresponding Author: Murtuza Bharmal, PhD
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 180 180 20
PDF Downloads 174 174 6
EPUB Downloads 0 0 0